Small-Cap Catalyst Pharmaceuticals Is Among Market's Best Price Performers
Small-cap biotech Catalyst Pharmaceuticals (NASDAQ:CPRX) has been outperforming the broader market, amid recent earnings and revenue acceleration.
Ray Dalio Hedge Fund Letters Database Now Live Apellis Pharmaceuticals While Catalyst Pharmaceuticals Verona Pharmaceuticals Catalyst Pharmaceuticals
Source: valuewalk.com